Castle Biosciences(CSTL)
$32.98+0.23 (+0.70%)
CSTL
Castle Biosciences hedge funds
$32.98
At close:+0.23 (+0.70%)
Want to see CSTL full AI Analyst Report?
Castle Biosciences (CSTL) Hedge Fund Trading Activity
474 Followers
Trend: ▲ Hedge Funds Increased Holdings by 306.8K Shares Last Quarter
Hedge Fund Holdings in CSTL
Based on the 13F filings of 489 Hedge Funds tracked by TipRanks, as submitted to the SEC.
Hedge Fund Confidence Signal
Hedge Fund Activity
Activity
Star Ranking
| EntryPoint Capital, LLC | New | 100.00% | $213,267 | 0.05% | |||
| Added | 10.36% | $78,513,318 | <0.01% | ||||
| Graham Capital Management, L.P. | Sold Out | -100.00% | $0 | 0.00% |
FAQ
Which hedge funds hold Castle Biosciences?
The hedge funds that hold the most shares in Castle Biosciences are BlackRock, Inc., Andrew Alkon and Kenneth Tropin.
Are hedge funds buying or selling CSTL?
In the last quarter hedge funds have Increased their holdings in Castle Biosciences by 306.8K shares.
Where can I see a list of the best rated hedge funds?
You can see a list of the best hedge funds here.
Who is the best-performing hedge fund manager?
The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
Does Warren Buffet hold shares in Castle Biosciences stock?
Warren Buffet currently does not own shares in Castle Biosciences.
What is a 13F filing, and how does it help investors?
A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here

